ETF Series Solutions

615 East Michigan Street | Milwaukee, Wisconsin 53202

January 3, 2022

VIA EDGAR TRANSMISSION

U.S. Securities and Exchange Commission

Division of Investment Management

100 F Street NE

Washington, DC 20549

Re:			ETF Series Solutions (the “Trust”) File Nos.: 333-179562 and 811-22668 Loncar Cancer Immunotherapy ETF (S000050740) Loncar China BioPharma ETF (S000062680) Roundhill Acquirers Deep Value ETF (S000046243)

Dear Sir or Madam:

Pursuant to Rule 497(j) under the Securities Act of 1933, as amended, the Trust on behalf of its series listed in Appendix A, hereby certifies that the form of Prospectuses and Statements of Additional Information that would have been filed under Rule 497(b) or (c) would not have differed from that contained in Post-Effective Amendment No. 772 to the Trust’s Registration Statement on Form N‑1A, which was electronically filed with the Commission on December 17, 2021.

If you have any questions, please do not hesitate to contact me at (920) 360-7173 or alyssa.bernard@usbank.com.

Sincerely,

/s/ Alyssa Bernard    

Alyssa Bernard

Vice President

Appendix A

Loncar Cancer Immunotherapy ETF

Loncar China BioPharma ETF

Roundhill Acquirers Deep Value ETF